110 related articles for article (PubMed ID: 26179887)
1. Docetaxel-induced scleroderma: a case report and its role in the production of extracellular matrix.
Yang JQ; Dou TT; Chen XB; Min M; Cai SQ; Zheng M; Man XY
Int J Rheum Dis; 2017 Nov; 20(11):1835-1837. PubMed ID: 26179887
[No Abstract] [Full Text] [Related]
2. Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.
Postiglione L; Ladogana P; Montagnani S; di Spigna G; Castaldo C; Turano M; Bruno EM; Di Meglio F; Riccio A; Rossi G
J Rheumatol; 2005 Apr; 32(4):656-64. PubMed ID: 15801021
[TBL] [Abstract][Full Text] [Related]
3. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
[TBL] [Abstract][Full Text] [Related]
4. Systemic sclerosis with multiple nodules: characterization of the extracellular matrix.
Moinzadeh P; Agarwal P; Bloch W; Orteu C; Hunzelmann N; Eckes B; Krieg T
Arch Dermatol Res; 2013 Sep; 305(7):645-52. PubMed ID: 23836353
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated interleukin-23 signalling contributes to the increased collagen production in scleroderma fibroblasts via balancing microRNA expression.
Nakayama W; Jinnin M; Tomizawa Y; Nakamura K; Kudo H; Inoue K; Makino K; Honda N; Kajihara I; Fukushima S; Ihn H
Rheumatology (Oxford); 2017 Jan; 56(1):145-155. PubMed ID: 27744356
[TBL] [Abstract][Full Text] [Related]
6. Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.
Iannone F; Matucci-Cerinic M; Falappone PC; Guiducci S; Cinelli M; Distler O; Lapadula G
J Rheumatol; 2005 Oct; 32(10):1893-8. PubMed ID: 16206343
[TBL] [Abstract][Full Text] [Related]
7. Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma.
Chan ES; Fernandez P; Merchant AA; Montesinos MC; Trzaska S; Desai A; Tung CF; Khoa DN; Pillinger MH; Reiss AB; Tomic-Canic M; Chen JF; Schwarzschild MA; Cronstein BN
Arthritis Rheum; 2006 Aug; 54(8):2632-42. PubMed ID: 16871530
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel-induced palmoplantar erythrodysesthesia syndrome and long-lasting multiple nail changes.
Akoglu G
Indian J Pharmacol; 2014; 46(2):225-7. PubMed ID: 24741199
[TBL] [Abstract][Full Text] [Related]
10. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis.
Huber LC; Distler JH; Moritz F; Hemmatazad H; Hauser T; Michel BA; Gay RE; Matucci-Cerinic M; Gay S; Distler O; Jüngel A
Arthritis Rheum; 2007 Aug; 56(8):2755-64. PubMed ID: 17665426
[TBL] [Abstract][Full Text] [Related]
11. Squamous differentiation in breast carcinoma following neo-adjuvant chemotherapy: Therapy effect vs tumor heterogeneity.
Patil PA; Singh K; Paquette C; Quddus MR
Breast J; 2018 Sep; 24(5):823-824. PubMed ID: 29687533
[No Abstract] [Full Text] [Related]
12. Case records of the Massachusetts General Hospital. Case 35-2005. A 56-year-old woman with breast cancer and isolated tumor cells in a sentinel lymph node.
Davidson NE; Morrow M; Kopans DB; Koerner FC
N Engl J Med; 2005 Nov; 353(20):2177-85. PubMed ID: 16291988
[No Abstract] [Full Text] [Related]
13. Trastuzumab use for metastatic breast cancer in pregnancy.
Sekar R; Stone PR
Obstet Gynecol; 2007 Aug; 110(2 Pt 2):507-10. PubMed ID: 17666645
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-related scleredema-like skin changes in a patient with breast cancer.
Tani N; Sugita K; Yamamoto O
Australas J Dermatol; 2018 Aug; 59(3):e215-e217. PubMed ID: 28944958
[No Abstract] [Full Text] [Related]
15. Fibroblasts and extracellular matrix: Targeting and therapeutic tools in fibrosis and cancer.
Prakash J; Pinzani M
Adv Drug Deliv Rev; 2017 Nov; 121():1-2. PubMed ID: 29191284
[No Abstract] [Full Text] [Related]
16. Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers.
Ooe A; Kato K; Noguchi S
Breast Cancer Res Treat; 2007 Mar; 101(3):305-15. PubMed ID: 16821082
[TBL] [Abstract][Full Text] [Related]
17. [Docetaxel plus carboplatin versus EC-T as adjuvant chemotherapy for triple-negative breast cancer: safety data from a phase III randomized open-label trial].
Yuan P; Xu BH; Wang JY; Ma F; Li Q; Zhang P; Fan Y; Li Q; Wang WM
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):465-8. PubMed ID: 22967451
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-induced scleroderma: a pleiomorphic syndrome.
Alexandrescu DT; Bhagwati NS; Wiernik PH
Clin Exp Dermatol; 2005 Mar; 30(2):141-5. PubMed ID: 15725240
[TBL] [Abstract][Full Text] [Related]
19. On the recovery of trastuzumab-related cardiac dysfunction.
Gillham CM; Chalmers AC; Plowman PN
Clin Oncol (R Coll Radiol); 2001; 13(2):146. PubMed ID: 11373881
[No Abstract] [Full Text] [Related]
20. [Transforming growth factor-beta and its receptors in scleroderma].
QIAN H; ZHENG M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):415-21. PubMed ID: 19693982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
